Position in ATYR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$54,243
-$17,415 QoQ
Shares Held
90,861
-1.1% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 90 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 24%
Shared 69%
None 7%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ATYR ranks #216 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ATYR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,243 | 90,861 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $71,658 | 91,871 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $76,339 | 97,497 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $154,686 | 214,546 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,087,746 | 214,546 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $688,842 | 228,094 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $880,995 | 243,369 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $256,122 | 145,524 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $227,016 | 145,524 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $383,649 | 196,744 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $200,568 | 142,248 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $373,588 | 236,449 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $600,056 | 277,804 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $310,323 | 147,773 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $432,945 | 197,692 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $508,080 | 169,360 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $417,696 | 147,596 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,082,219 | 202,284 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,693,538 | 226,712 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,036,453 | 224,279 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,078,128 | 220,928 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $286,580 | 64,400 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $74,224 | 19,130 | Shares | Sole | 2021-03-08 | |
| 2020-09-30 | $61,789 | 19,130 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $73,837 | 16,630 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $78,187 | 27,924 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||